LAMP1 and neoplasm: We designed a cancer vaccine utilizing our nucleic acid platform, UNITETM (UNiversal Intracellular Targeted Expression), which fuses a tumor-associated antigen with lysosomal-associated membrane protein 1 (LAMP1).